The Impact of Age on Treatment Responses in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
Objective: The correlation between age and the incidence and prevalence of cancer is well-established. Immunosenescence is thought to be underlying this condition. This retrospective research aimed to investigate the impact of aging on the responses to immune checkpoint inhibitor (ICIs) treatment re...
Saved in:
| Main Authors: | Gülin Alkan Şen, Hande Turna |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AVES
2024-12-01
|
| Series: | Cerrahpaşa Medical Journal |
| Online Access: | https://cerrahpasamedj.org/en/the-impact-of-age-on-treatment-responses-in-patients-with-non-small-cell-lung-cancer-treated-with-immune-checkpoint-inhibitors-131270 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors
by: Yusuke Hamakawa, et al.
Published: (2025-01-01) -
Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?
by: Kartik Sehgal, et al.
Published: (2020-05-01) -
Correction: Complete metabolic response in patients with advanced non-small cell lung cancer with prolonged response to immune checkpoint inhibitor therapy
Published: (2021-06-01) -
Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors
by: Martina Catalano, et al.
Published: (2024-11-01) -
Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer
by: Furnback W, et al.
Published: (2025-02-01)